The Repurposing of Cellular Proteins during Enterovirus A71 Infection
Viruses pose a great threat to people’s lives. Enterovirus A71 (EV-A71) infects children and infants all over the world with no FDA-approved treatment to date. Understanding the basic mechanisms of viral processes aids in selecting more efficient drug targets and designing more effective antivirals...
Main Authors: | Sudeshi M. Abedeera, Jesse Davila-Calderon, Christina Haddad, Barrington Henry, Josephine King, Srinivasa Penumutchu, Blanton S. Tolbert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/16/1/75 |
Similar Items
-
Neutralizing Antibodies to Enterovirus 71 in Belém, Brazil
by: Maria de Lourdes C Gomes, et al.
Published: (2002-01-01) -
Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
by: Salima Lalani, et al.
Published: (2021-08-01) -
Enterovirus A71 Vaccines
by: Mei-Ling Li, et al.
Published: (2021-02-01) -
Beclin1 Binds to Enterovirus 71 3D Protein to Promote the Virus Replication
by: Qi Xiang, et al.
Published: (2020-07-01) -
Tribbles pseudokinase 3 promotes enterovirus A71 infection via dual mechanisms
by: Huiqiang Wang, et al.
Published: (2024-12-01)